Funded with over £3million from 5 founding donors, the new Imperial Centre for Psychedelic Research will build on over a decade of pharmaceutical work, including psilocybin for depression; it will also investigate drugs for anorexia.
Funded with over £3million from 5 founding donors, the new Imperial Centre for Psychedelic Research will build on over a decade of pharmaceutical work, including psilocybin for depression; it will also investigate drugs for anorexia.